The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
From Discovery to Disease Prevention: How the Biose–Siolta Partnership is Advancing a New Generation of Live Biotherapeutics• A pioneering gut bacterium passes Europe’s food-safety review under the EU Novel Food Regulation• Stanford’s AI Designed Bacteriophages: Ushering in the Next Phase in IP Strategy for Phage Companies?• Breathing Engineered Bacteria: A New Approach to Treating Lung Disease• Vedanta Biosciences Secures $60 Million in Funding Ahead of Pivotal Phase 3 Data• Gut fungi may hold the key to treating Asthma worldwide•

Category: Clinical & Manufacturing

BMS and Vedanta Announce Clinical Collaboration to Evaluate OPDIVO and VE800 in Patients with Advanced or Metastatic Cancers
Clinical & Manufacturing

BMS and Vedanta Announce Clinical Collaboration to Evaluate OPDIVO and VE800 in Patients with Advanced or Metastatic Cancers

DEC 10, 2018
MaaT Pharma Presents Positive Phase 1b/2a Study Results in Acute Myeloid Leukemia Patients
Clinical & Manufacturing

MaaT Pharma Presents Positive Phase 1b/2a Study Results in Acute Myeloid Leukemia Patients

DEC 3, 2018
Vedanta Biosciences Announces Initiation of Phase 1 Clinical Study with Janssen of Microbiome-Derived Product Candidate for IBD
Clinical & Manufacturing

Vedanta Biosciences Announces Initiation of Phase 1 Clinical Study with Janssen of Microbiome-Derived Product Candidate for IBD

NOV 27, 2018
Synthetic Biologics Announces Positive Outcome of End-of-Phase 2 Meeting with FDA on SYN-004 (ribaxamase) Development
Clinical & Manufacturing

Synthetic Biologics Announces Positive Outcome of End-of-Phase 2 Meeting with FDA on SYN-004 (ribaxamase) Development

NOV 22, 2018
4D Pharma plc Announces First Patient Enrolment in Blautix IBS Phase II study
Clinical & Manufacturing

4D Pharma plc Announces First Patient Enrolment in Blautix IBS Phase II study

NOV 9, 2018
MaaT Pharma Announces First Patient Dosed in Phase 2 Clinical Trial of Lead Product MaaT013, a First-in-Class Biotherapeutic to Treat Acute GvHD
Clinical & Manufacturing

MaaT Pharma Announces First Patient Dosed in Phase 2 Clinical Trial of Lead Product MaaT013, a First-in-Class Biotherapeutic to Treat Acute GvHD

OCT 15, 2018
Ilya Pharma Raises Additional €3 million to Take Novel ATMP Through to Phase II for Wound Care
Clinical & Manufacturing

Ilya Pharma Raises Additional €3 million to Take Novel ATMP Through to Phase II for Wound Care

SEP 14, 2018
Women with gas and bloating: Probiotic clinical trial outcomes
Clinical & Manufacturing

Women with gas and bloating: Probiotic clinical trial outcomes

SEP 6, 2018
OxThera Phase 3 Study With Oxabact® in Primary Hyperoxaluria is Now Open for Recruitment
Clinical & Manufacturing

OxThera Phase 3 Study With Oxabact® in Primary Hyperoxaluria is Now Open for Recruitment

JUL 15, 2018
Lactobacillus reuteri Reduced Bone Loss in Older Women
Clinical & Manufacturing

Lactobacillus reuteri Reduced Bone Loss in Older Women

JUN 26, 2018
MHRA and HPRA Clear 4D Pharma’s Blautix Phase II Study
Clinical & Manufacturing

MHRA and HPRA Clear 4D Pharma’s Blautix Phase II Study

JUN 14, 2018